$679 Million is the total value of TANG CAPITAL MANAGEMENT LLC's 99 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 46.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ANAB | Sell | ANAPTYSBIO INC | $39,675,387 | -10.3% | 1,950,609 | -4.0% | 5.84% | -11.4% |
| TARS | Sell | TARSUS PHARMACEUTICALS INC | $32,149,385 | +25.7% | 1,779,158 | -12.5% | 4.73% | +24.2% |
| MIRM | Sell | MIRUM PHARMACEUTICALS INC | $29,416,958 | +4.7% | 1,137,107 | -2.8% | 4.33% | +3.4% |
| IMGN | Buy | IMMUNOGEN INC | $24,531,000 | +401.1% | 1,300,000 | +2.0% | 3.61% | +395.3% |
| IMCR | IMMUNOCORE HLDGS PLCads | $24,319,776 | +21.3% | 405,600 | 0.0% | 3.58% | +19.8% | |
| BLUE | Sell | BLUEBIRD BIO INC | $24,289,501 | -22.7% | 7,382,827 | -25.3% | 3.58% | -23.6% |
| KALV | KALVISTA PHARMACEUTICALS INC | $23,862,537 | +14.5% | 2,651,393 | 0.0% | 3.51% | +13.1% | |
| AXSM | AXSOME THERAPEUTICS INC | $22,995,200 | +16.5% | 320,000 | 0.0% | 3.38% | +15.1% | |
| EOLS | Sell | EVOLUS INC | $22,518,091 | -16.8% | 3,097,399 | -3.1% | 3.32% | -17.8% |
| ITCI | INTRA-CELLULAR THERAPIES INC | $18,996,000 | +16.9% | 300,000 | 0.0% | 2.80% | +15.5% | |
| NYCB | NEW YORK CMNTY BANCORP INC | $18,058,184 | +24.3% | 1,606,600 | 0.0% | 2.66% | +22.9% | |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $17,248,000 | +29.3% | 2,450,000 | +53.1% | 2.54% | +27.7% |
| VRDN | VIRIDIAN THERAPEUTICS INC | $16,484,686 | -6.5% | 692,925 | 0.0% | 2.43% | -7.6% | |
| BGNE | BEIGENE LTDsponsored adr | $15,155,500 | -17.3% | 85,000 | 0.0% | 2.23% | -18.3% | |
| PCVX | VAXCYTE INC | $14,982,000 | +33.2% | 300,000 | 0.0% | 2.21% | +31.7% | |
| LLY | LILLY ELI & CO | $14,069,400 | +36.6% | 30,000 | 0.0% | 2.07% | +34.9% | |
| IFRX | New | INFLARX NV | $12,934,000 | – | 2,900,000 | +100.0% | 1.90% | – |
| AZN | ASTRAZENECA PLCsponsored adr | $12,166,900 | +3.1% | 170,000 | 0.0% | 1.79% | +1.9% | |
| CTMX | Buy | CYTOMX THERAPEUTICS INC | $11,352,000 | +23.4% | 6,600,000 | +8.3% | 1.67% | +21.9% |
| AVIR | Buy | ATEA PHARMACEUTICALS INC | $11,318,942 | +237.0% | 3,026,455 | +201.9% | 1.67% | +233.2% |
| BCAB | Buy | BIOATLA INC | $11,022,228 | +13.5% | 3,674,076 | +1.4% | 1.62% | +12.2% |
| ALT | ALTIMMUNE INC | $9,707,500 | -16.4% | 2,750,000 | 0.0% | 1.43% | -17.4% | |
| HRMY | Sell | HARMONY BIOSCIENCES HLDGS IN | $9,543,528 | -9.0% | 271,200 | -15.6% | 1.40% | -10.1% |
| ZYMEWORKS DEL INC | $9,504,000 | -4.4% | 1,100,000 | 0.0% | 1.40% | -5.6% | ||
| MRNA | Sell | MODERNA INC | $9,319,050 | -55.6% | 76,700 | -43.9% | 1.37% | -56.1% |
| COF | Sell | CAPITAL ONE FINL CORP | $8,749,600 | -9.0% | 80,000 | -20.0% | 1.29% | -10.1% |
| THIRD HARMONIC BIO INC | $8,658,000 | +16.7% | 1,800,000 | 0.0% | 1.28% | +15.4% | ||
| New | VERASTEM INC | $8,481,600 | – | 1,140,000 | +100.0% | 1.25% | – | |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $8,449,000 | +4.3% | 7,100,000 | +31.5% | 1.24% | +3.1% |
| KNSA | KINIKSA PHARMACEUTICALS LTD | $8,448,000 | +30.9% | 600,000 | 0.0% | 1.24% | +29.3% | |
| IONS | IONIS PHARMACEUTICALS INC | $8,206,000 | +14.8% | 200,000 | 0.0% | 1.21% | +13.4% | |
| ELEV | Buy | ELEVATION ONCOLOGY INC | $6,080,000 | +128.6% | 4,000,000 | +185.7% | 0.90% | +126.0% |
| BIO | BIO RAD LABS INCcl a | $6,065,920 | -20.9% | 16,000 | 0.0% | 0.89% | -21.8% | |
| ACET | Sell | ADICET BIO INC | $6,025,311 | -58.5% | 2,479,552 | -1.6% | 0.89% | -59.0% |
| CRTX | Sell | QUINCE THERAPEUTICS INC | $5,437,986 | -3.7% | 3,613,280 | -0.2% | 0.80% | -4.8% |
| GRPH | Buy | GRAPHITE BIO INC | $5,422,625 | +9.1% | 2,085,625 | +2.8% | 0.80% | +7.7% |
| CGEM | Sell | CULLINAN ONCOLOGY INC | $4,842,000 | -5.3% | 450,000 | -10.0% | 0.71% | -6.4% |
| ADMA | New | ADMA BIOLOGICS INC | $4,649,400 | – | 1,260,000 | +100.0% | 0.68% | – |
| C | CITIGROUP INC | $4,604,000 | -1.8% | 100,000 | 0.0% | 0.68% | -3.0% | |
| MGTA | Buy | MAGENTA THERAPEUTICS INC | $4,593,480 | -4.5% | 6,060,000 | +0.2% | 0.68% | -5.6% |
| Sell | PYXIS ONCOLOGY INC | $4,576,704 | -54.0% | 1,787,775 | -28.0% | 0.67% | -54.6% | |
| ADAP | New | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $4,520,695 | – | 4,887,238 | +100.0% | 0.67% | – |
| RAIN | New | RAIN ONCOLOGY INC | $4,488,409 | – | 3,740,341 | +100.0% | 0.66% | – |
| GNFT | Buy | GENFIT S Aads | $4,369,903 | -12.1% | 1,234,436 | +1.8% | 0.64% | -13.2% |
| BOLT | Buy | BOLT BIOTHERAPEUTICS INC | $4,267,268 | +88.6% | 3,333,803 | +104.8% | 0.63% | +86.4% |
| ENZ | ENZO BIOCHEM INC | $4,232,000 | -24.3% | 2,300,000 | 0.0% | 0.62% | -25.2% | |
| NVCR | New | NOVOCURE LTD | $4,150,000 | – | 100,000 | +100.0% | 0.61% | – |
| Sell | ASLAN PHARMACEUTICALS LTDspon ads new | $4,117,448 | +22.7% | 1,128,068 | -3.2% | 0.61% | +21.2% | |
| DVAX | DYNAVAX TECHNOLOGIES CORP | $3,876,000 | +31.7% | 300,000 | 0.0% | 0.57% | +30.1% | |
| VBTX | Buy | VERITEX HLDGS INC | $3,765,300 | +87.5% | 210,000 | +90.9% | 0.55% | +85.3% |
| GLPG | GALAPAGOS NVspon adr | $3,645,169 | +5.2% | 89,650 | 0.0% | 0.54% | +4.1% | |
| PHAT | New | PHATHOM PHARMACEUTICALS INC | $3,580,000 | – | 250,000 | +100.0% | 0.53% | – |
| Buy | PARDES BIOSCIENCES INC | $3,520,823 | +789.1% | 1,945,206 | +548.4% | 0.52% | +778.0% | |
| INSM | INSMED INC | $3,506,883 | +23.8% | 166,203 | 0.0% | 0.52% | +22.3% | |
| BIOHAVEN LTD | $3,348,800 | +75.1% | 140,000 | 0.0% | 0.49% | +73.0% | ||
| FATE | FATE THERAPEUTICS INC | $3,332,000 | -16.5% | 700,000 | 0.0% | 0.49% | -17.5% | |
| USB | New | US BANCORP DEL | $3,304,000 | – | 100,000 | +100.0% | 0.49% | – |
| ALGS | Sell | ALIGOS THERAPEUTICS INC | $3,232,506 | +8.0% | 3,329,048 | -2.8% | 0.48% | +6.7% |
| NKTX | Sell | NKARTA INC | $3,034,966 | -52.1% | 1,385,829 | -22.4% | 0.45% | -52.7% |
| MRTX | New | MIRATI THERAPEUTICS INC | $2,890,400 | – | 80,000 | +100.0% | 0.43% | – |
| SBTX | ARS PHARMACEUTICALS INC | $2,743,402 | +2.9% | 409,463 | 0.0% | 0.40% | +1.8% | |
| CVBF | CVB FINL CORP | $2,656,000 | -20.4% | 200,000 | 0.0% | 0.39% | -21.3% | |
| ESPR | ESPERION THERAPEUTICS INC NE | $2,571,500 | -12.6% | 1,850,000 | 0.0% | 0.38% | -13.5% | |
| AVRO | Buy | AVROBIO INC | $2,570,021 | +6732.8% | 2,705,000 | +7091.7% | 0.38% | +6200.0% |
| 2SEVENTY BIO INC | $2,530,000 | -0.8% | 250,000 | 0.0% | 0.37% | -2.1% | ||
| New | MEI PHARMA INC | $2,375,933 | – | 361,084 | +100.0% | 0.35% | – | |
| EGRX | Buy | EAGLE PHARMACEUTICALS INC | $2,310,580 | +1.8% | 118,857 | +48.6% | 0.34% | +0.6% |
| Buy | LIANBIOsponsored ads | $2,193,410 | +433.9% | 962,022 | +359.0% | 0.32% | +429.5% | |
| AMYLYX PHARMACEUTICALS INC | $2,157,000 | -26.5% | 100,000 | 0.0% | 0.32% | -27.2% | ||
| BKU | BANKUNITED INC | $2,155,000 | -4.6% | 100,000 | 0.0% | 0.32% | -5.7% | |
| HRTX | Buy | HERON THERAPEUTICS INC | $2,146,000 | +158.4% | 1,850,000 | +236.4% | 0.32% | +154.8% |
| EQC | EQUITY COMWLTH | $2,026,000 | -2.2% | 100,000 | 0.0% | 0.30% | -3.6% | |
| ARVN | ARVINAS INC | $1,985,600 | -9.2% | 80,000 | 0.0% | 0.29% | -10.4% | |
| CHRS | Buy | COHERUS BIOSCIENCES INC | $1,708,000 | +24.9% | 400,000 | +100.0% | 0.25% | +23.0% |
| EDIT | New | EDITAS MEDICINE INC | $1,646,000 | – | 200,000 | +100.0% | 0.24% | – |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $1,452,000 | – | 150,000 | +100.0% | 0.21% | – |
| BOH | New | BANK HAWAII CORP | $1,236,900 | – | 30,000 | +100.0% | 0.18% | – |
| SFBS | SERVISFIRST BANCSHARES INC | $1,227,600 | -25.1% | 30,000 | 0.0% | 0.18% | -25.8% | |
| Buy | INVIVYD INC | $1,209,435 | +152.0% | 1,151,843 | +188.0% | 0.18% | +147.2% | |
| CRSP | New | CRISPR THERAPEUTICS AGnamen akt | $1,122,800 | – | 20,000 | +100.0% | 0.16% | – |
| ATHA | ATHIRA PHARMA INC | $1,040,509 | +18.0% | 352,715 | 0.0% | 0.15% | +16.8% | |
| Buy | INSPIRATO INCORPORATED | $1,014,300 | +178.4% | 1,035,000 | +172.4% | 0.15% | +175.9% | |
| ASND | New | ASCENDIS PHARMA A/Ssponsored adr | $892,500 | – | 10,000 | +100.0% | 0.13% | – |
| NXTC | NEXTCURE INC | $720,000 | +21.6% | 400,000 | 0.0% | 0.11% | +20.5% | |
| MASS | New | 908 DEVICES INC | $686,000 | – | 100,000 | +100.0% | 0.10% | – |
| TANGO THERAPEUTICS INC | $664,000 | -15.9% | 200,000 | 0.0% | 0.10% | -16.9% | ||
| PDSB | New | PDS BIOTECHNOLOGY CORP | $503,000 | – | 100,000 | +100.0% | 0.07% | – |
| Buy | STELLAR BANCORP INC | $457,800 | +86.0% | 20,000 | +100.0% | 0.07% | +81.1% | |
| SELB | New | SELECTA BIOSCIENCES INC | $448,000 | – | 400,000 | +100.0% | 0.07% | – |
| STIM | New | NEURONETICS INC | $430,000 | – | 200,000 | +100.0% | 0.06% | – |
| New | GENEDX HOLDINGS CORP | $379,273 | – | 63,636 | +100.0% | 0.06% | – | |
| LIFE | Buy | ATYR PHARMA INC | $324,000 | +25.0% | 150,000 | +21.5% | 0.05% | +23.1% |
| EQ | Buy | EQUILLIUM INC | $300,000 | +364.0% | 400,000 | +351.6% | 0.04% | +340.0% |
| PASG | PASSAGE BIO INC | $282,390 | -1.7% | 300,000 | 0.0% | 0.04% | -2.3% | |
| New | FREELINE THERAPEUTICS HLDGSsponsored ads | $258,000 | – | 100,000 | +100.0% | 0.04% | – | |
| MOLN | Buy | MOLECULAR PARTNERS AGads | $247,264 | +7.1% | 39,753 | +3.9% | 0.04% | +5.9% |
| ACELRX PHARMACEUTICALS INC | $216,450 | +68.7% | 195,000 | 0.0% | 0.03% | +68.4% | ||
| CREG | New | SMART POWERR CORP | $202,599 | – | 125,061 | +100.0% | 0.03% | – |
| NKTR | NEKTAR THERAPEUTICS | $80,298 | -18.2% | 139,600 | 0.0% | 0.01% | -20.0% | |
| VINC | Exit | VINCERX PHARMA INC | $0 | – | -101,762 | -100.0% | -0.02% | – |
| TIL | Exit | INSTIL BIO INC | $0 | – | -200,000 | -100.0% | -0.02% | – |
| CYT | Exit | CYTEIR THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.03% | – |
| RVPH | Exit | REVIVA PHARMACEUTCLS HLDGS I | $0 | – | -53,200 | -100.0% | -0.03% | – |
| Exit | ORCHARD THERAPEUTICS PLCspon ads new | $0 | – | -50,000 | -100.0% | -0.04% | – | |
| KRON | Exit | KRONOS BIO INC | $0 | – | -200,000 | -100.0% | -0.04% | – |
| Exit | TONIX PHARMACEUTICALS HLDG C | $0 | – | -1,100,419 | -100.0% | -0.10% | – | |
| VNDA | Exit | VANDA PHARMACEUTICALS INC | $0 | – | -100,000 | -100.0% | -0.10% | – |
| SURF | Exit | SURFACE ONCOLOGY INC | $0 | – | -1,300,000 | -100.0% | -0.14% | – |
| SCYX | Exit | SCYNEXIS INC | $0 | – | -383,179 | -100.0% | -0.17% | – |
| UMBF | Exit | UMB FINL CORP | $0 | – | -20,000 | -100.0% | -0.17% | – |
| MEIP | Exit | MEI PHARMA INC | $0 | – | -5,163,456 | -100.0% | -0.18% | – |
| IBRX | Exit | IMMUNITYBIO INC | $0 | – | -1,095,795 | -100.0% | -0.30% | – |
| ALLK | Exit | ALLAKOS INC | $0 | – | -447,967 | -100.0% | -0.30% | – |
| BLU | Exit | BELLUS HEALTH INC NEW | $0 | – | -300,000 | -100.0% | -0.32% | – |
| RXDX | Exit | PROMETHEUS BIOSCIENCES INC | $0 | – | -21,000 | -100.0% | -0.34% | – |
| RCUS | Exit | ARCUS BIOSCIENCES INC | $0 | – | -147,920 | -100.0% | -0.40% | – |
| ITOS | Exit | ITEOS THERAPEUTICS INC | $0 | – | -216,700 | -100.0% | -0.44% | – |
| ENTA | Exit | ENANTA PHARMACEUTICALS INC | $0 | – | -90,000 | -100.0% | -0.54% | – |
| FRC | Exit | FIRST REP BK SAN FRANCISCO C | $0 | – | -278,759 | -100.0% | -0.58% | – |
| TCRR | Exit | TCR2 THERAPEUTICS INC | $0 | – | -3,399,745 | -100.0% | -0.76% | – |
| CMA | Exit | COMERICA INC | $0 | – | -133,525 | -100.0% | -0.86% | – |
| BLPH | Exit | BELLEROPHON THERAPEUTICS INC | $0 | – | -893,974 | -100.0% | -1.05% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -45,000 | -100.0% | -1.34% | – |
| JNCE | Exit | JOUNCE THERAPEUTICS INC | $0 | – | -5,300,087 | -100.0% | -1.46% | – |
| NVO | Exit | NOVO-NORDISK A Sadr | $0 | – | -135,000 | -100.0% | -3.20% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HERON THERAPEUTICS INC | 40 | Q2 2024 | 55.0% |
| LA JOLLA PHARMACEUTICAL CO | 34 | Q2 2022 | 37.1% |
| ROCKET PHARMACEUTICALS INC | 23 | Q2 2024 | 31.6% |
| ANAPTYSBIO INC | 19 | Q2 2024 | 18.4% |
| BIOMARIN PHARMACEUTICAL INC | 18 | Q3 2017 | 12.1% |
| ODONATE THERAPEUTICS INC | 17 | Q4 2021 | 69.8% |
| COHERUS BIOSCIENCES INC | 16 | Q2 2024 | 2.7% |
| RELMADA THERAPEUTICS INC | 14 | Q2 2024 | 6.2% |
| EQUILLIUM INC | 14 | Q4 2023 | 1.2% |
| ALTIMMUNE INC | 13 | Q2 2024 | 6.5% |
View TANG CAPITAL MANAGEMENT LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-14 |
| 4 | 2024-02-02 |
| 4 | 2023-12-18 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-10-13 |
| 13F-HR | 2023-08-14 |
View TANG CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.